Eversana – Healthcare Data News

EVERSANA Unveils TEDAVI, the Breakthrough Content Creation Hub to Transform Agency Marketing Models and Maximize Brand Impact

CHICAGO, Aug. 1, 2024 /PRNewswire/ — EVERSANA, a leading provider of global commercial services to the life sciences industry, today introduced TEDAVI, the pharmaceutical and life science industry’s premier content transformation hub built to...

June 1, 2023June 5, 2023 China Collaborations Competitor News International

EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally

BEIJING, June 1, 2023 /PRNewswire/ — EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today announced that it has established a strategic alliance with the China Resources Pharmaceutical...

May 22, 2023May 22, 2023 Collaborations Competitor News Pharma

Yaral Pharma Partners With EVERSANA to Support the Commercialization of Its Expanding Generics Portfolio

Partnership Supports Commitment to Providing High-Quality Products, Supply Chain Continuity, and Exceptional Customer Service May 22, 2023 08:00 AM Eastern Daylight Time PARSIPPANY, N.J.–(BUSINESS WIRE)–Yaral Pharma Inc., (Yaral Pharma) the...

February 23, 2023February 27, 2023 Collaborations Competitor News

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

STOCKHOLM, Feb. 23, 2023 /PRNewswire/ — Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc for the treatment...

February 8, 2023February 13, 2023 Awards Competitor News Marketing

EVERSANA CONSULTING Named a Best Boutique Consulting Firm by Vault For the Second Consecutive Year

CHICAGO, Feb. 8, 2023 /PRNewswire/ — EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today announced its strategic consulting arm EVERSANA® CONSULTING has been named to Vault’s 2023 Best Boutique Consulting...

November 14, 2022November 21, 2022 Competitor News HR

EVERSANA® Names Experienced Life Sciences Leader Sy Pretorius Chief Operating Officer & President, Outsourced Solutions to Propel Next-Generation Commercialization Services Worldwide

CHICAGO, Nov. 14, 2022 /PRNewswire/ — EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today named Sy Pretorius as the company’s new Chief Operating Officer and President, Outsourced...

September 27, 2022October 4, 2022 Collaborations Competitor News Data Partnership

Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.

CHICAGO and LOUGHBOROUGH, Sept. 27, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising noninvasive wearable diagnostic devices and supporting...

September 26, 2022October 4, 2022 Collaborations Competitor News Data Partnership

Prosoma Digital Therapeutics and EVERSANA Announce Commercialisation Partnership for New Therapeutic Supporting Mental Health and Behavioural Needs of Cancer Patients

CHICAGO and WARSAW, Poland, Sept. 26, 2022 /PRNewswire/ — Prosoma Digital Therapeutics, innovators in reinventing healthcare for oncology patients, has partnered with EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, to...

July 12, 2022July 15, 2022 Asia-Pacific Collaborations Competitor News Data Partnership International

EVERSANA™ Announces Strategic Partnership with Compai Pharma to Expand Commercialisation Services Across the Asia Pacific Region

CHICAGO and SINGAPORE, July 12, 2022 /PRNewswire/ — EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry with its Asian regional headquarters in Singapore and offices across Japan, China and other countries in the area, and...

June 29, 2022July 4, 2022 Collaborations Competitor News Data Partnership Oncology Pharma

Accord BioPharma and EVERSANA Announce Partnership to Support the Launch of CAMCEVI® for the Treatment of Advanced Prostate Cancer in Adults in the U.S.

CHICAGO, June 29, 2022 /PRNewswire/ — EVERSANA, the pioneer of next-generation commercial services to the global life sciences industry, and Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., today announced a partnership...